Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.
Stone RL, Sood AK, Coleman RL. Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer. Lancet Oncol. 2010 May; 11(5):465-75.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Cardiovascular Diseases
Endocrine System Diseases
Female
Gastrointestinal Diseases
Humans
Ovarian Neoplasms
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Skin Diseases
authors with profiles
Krishna Nalleballe
Jose Romero